SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Costantino who wrote (249)7/20/1996 9:15:00 PM
From: Steve Jordan   of 4342
 
Rick,

The business week article is what turned my onto this stock. I've found some press releases and other articles under //biz.yahoo.com (quote section) as well. I have a couple of questions. Are compassionate use trials a step below Phase I clinical trials? Or do they have no scientific value as far as getting a compound approved? The PN355 drugs seems like a potential blockbuster if it can really stop HIV form destroying immune system cells. Also, I found out that they lost about $.83 cents a share last year. Does anyone know what their cash position is and how long they can keep operating before the money runs out (a classic problem for small biotech start-ups!) If anyone knows any answers to these questions, please let me know. This is a stock that I might buy as early as Monday if the answers to my questions sound good. Thanks in advance.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext